Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications

Tumor Biology

Volumn 36, Issue 3, 2015, Pages 1781-1789

  Zhang, Chi ^a   Liu, Li Xin ^b   Dong, Zhao Ru ^a   Shi, Guo Ming ^a   Cai, Jia Bin ^a   Zhang, Peng Fei ^a   Ke, Ai Wu ^a   Yu, Jing Xian ^a   Zhou, Jian ^a   Fan, Jia ^a,c  

^a FUDAN UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

14 3 3 ; Epithelial mesenchymal transition; Intrahepatic cholangiocarcinoma; Metastasis

Indexed keywords

CADHERIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN 14 3 3;

BILE DUCT CARCINOMA; BILE DUCT TUMOR; BIOSYNTHESIS; CELL PROLIFERATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTRAHEPATIC BILE DUCT; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE; UPREGULATION;

14-3-3 PROTEINS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLANGIOCARCINOMA; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PHOSPHORYLATION; PROGNOSIS; UP-REGULATION;

EID: 84930901270     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2780-5     Document Type: Article

References (30)

1. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet 2014
2. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
3. Khan SA, Emadossadaty S, Ladep NG, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol. 2012;56:848–54.
4. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States. Part III: Liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–44.
5. Aitken A. 14-3-3 proteins: a historic overview. Semin Cancer Biol. 2006;16:162–72.
6. Morrison DK. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 2009;19:16–23.
7. Freeman AK, Morrison DK. 14-3-3 proteins: diverse functions in cell proliferation and cancer progression. Semin Cell Dev Biol. 2011;22:681–7.
8. Frasor J, Chang EC, Komm B, et al. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res. 2006;66:7334–40.
9. Neal CL, Yu D. 14-3-3ζ as a prognostic marker and therapeutic target for cancer. Expert Opin Ther Targets. 2010;14:1343–54.
10. Niemantsverdriet M, Wagner K, Visser M, et al. Cellular functions of 14-3-3 zeta in apoptosis and cell adhesion emphasize its oncogenic character. Oncogene. 2008;27:1315–9.
11. Fan T, Li R, Todd NW, et al. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res. 2007;67:7901–6.
12. Maxwell SA, Li Z, Jaye D, et al. 14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen. J Biol Chem. 2009;284:22379–89.
13. Lu J, Guo H, Treekitkarnmongkol W, et al. 14-3-3zeta cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell. 2009;16:195–207.
14. Huang XY, Ke AW, Shi GM, et al. AlphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology. 2013;57:2235–47.
15. Wittekind C. Pitfalls in the classification of liver tumors. Pathologe. 2006;27:289–93.
16. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.
17. Ke AW, Shi GM, Zhou J, et al. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology. 2009;49:491–503.
18. Zhang C, Bai DS, Huang XY, et al. Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma. PLoS One. 2013;8:e54619.
19. Ke AW, Shi GM, Zhou J, et al. CD151 amplifies signaling by integrin alpha6beta1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology. 2011;140:1629–41. e15.
20. Bai DS, Dai Z, Zhou J, et al. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology. 2009;49:460–70.
21. Neal CL, Yao J, Yang W, et al. 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res. 2009;69:3425–32.
22. Zhao GY, Ding JY, Lu CL, et al. The overexpression of 14-3-3zeta and Hsp27 promotes non-small cell lung cancer progression. Cancer. 2014;120:652–63.
23. Wu Q, Liu CZ, Tao LY, et al. The clinicopathological and prognostic impact of 14-3-3 protein isoforms expression in human cholangiocarcinoma by immunohistochemistry. Asian Pac J Cancer Prev. 2012;13:1253–9.
24. Zhao J, Meyerkord CL, Du Y, et al. 14-3-3 proteins as potential therapeutic targets. Semin Cell Dev Biol. 2011;22:705–12.
25. Lin M, Morrison CD, Jones S, et al. Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma. Int J Cancer. 2009;125:603–11.
26. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005;132:3151–61.
27. Hou Z, Peng H, White DE, et al. 14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation. Cancer Res. 2010;70:4385–93.
28. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864–70.
29. Gardino AK, Yaffe MB. 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin Cell Dev Biol. 2011;22:688–95.
30. Fischer A, Baljuls A, Reinders J, et al. Regulation of RAF activity by 14-3-3 proteins: RAF kinases associate functionally with both homo- and heterodimeric forms of 14-3-3 proteins. J Biol Chem. 2009;284:3183–94.